These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16033970)

  • 21. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women.
    Wang Y; Underwood J; Vaughan R; Harmer A; Doyle C; Lehner T
    Clin Exp Immunol; 2002 Sep; 129(3):493-501. PubMed ID: 12197891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic Modulation of Expression of Lentiviral Restriction Factors in Primary CD4
    Rahmberg AR; Rajakumar PA; Billingsley JM; Johnson RP
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
    Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
    J Virol; 2018 May; 92(9):. PubMed ID: 29467313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
    Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection.
    Tuero I; Venzon D; Robert-Guroff M
    J Immunol; 2016 Dec; 197(12):4686-4695. PubMed ID: 27815422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
    Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
    J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell responses in macaques after vaginal immunization with particulate SIV p27 antigen.
    Panagiotidi C; Bergmeier LA; Gearing AJ; Adams SE; Lehner T
    Adv Exp Med Biol; 1995; 371B():1575-80. PubMed ID: 7502859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication.
    Goldstein S; Brown CR; Dehghani H; Lifson JD; Hirsch VM
    J Virol; 2000 Oct; 74(20):9388-95. PubMed ID: 11000207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut.
    Wilson DP; Mattapallil JJ; Lay MD; Zhang L; Roederer M; Davenport MP
    J Virol; 2007 Aug; 81(15):8025-9. PubMed ID: 17507462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.
    Peng B; Voltan R; Lim L; Edghill-Smith Y; Phogat S; Dimitrov DS; Arora K; Leno M; Than S; Woodward R; Markham PD; Cranage M; Robert-Guroff M
    J Virol; 2002 Jun; 76(12):6016-26. PubMed ID: 12021334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus.
    Salvato MS; Emau P; Malkovsky M; Schultz KT; Johnson E; Pauza CD
    J Med Primatol; 1994; 23(2-3):125-30. PubMed ID: 7966226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.
    Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
    J Virol; 2002 Jan; 76(2):688-96. PubMed ID: 11752159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokine receptor CCR5 correlates with functional CD8
    Wang X; Russell-Lodrigue KE; Ratterree MS; Veazey RS; Xu H
    FASEB J; 2019 Aug; 33(8):8905-8912. PubMed ID: 31034775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection.
    Bogers WM; Bergmeier LA; Oostermeijer H; ten Haaft P; Wang Y; Kelly CG; Singh M; Heeney JL; Lehner T
    Vaccine; 2004 Aug; 22(23-24):2974-84. PubMed ID: 15356916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simian immunodeficiency virus types 1 and 2 (SIV mnd 1 and 2) have different pathogenic potentials in rhesus macaques upon experimental cross-species transmission.
    Souquière S; Onanga R; Makuwa M; Pandrea I; Ngari P; Rouquet P; Bourry O; Kazanji M; Apetrei C; Simon F; Roques P
    J Gen Virol; 2009 Feb; 90(Pt 2):488-499. PubMed ID: 19141460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.